{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:20:35Z","timestamp":1787019635810,"version":"build-2736575974"},"reference-count":67,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>An unmet clinical need in chronic lymphocytic leukemia (CLL) is emerging due to the rapidly expanding group of patients with double refractory (Bruton's tyrosine kinase- and B-cell lymphoma 2-inhibitor) disease. So far, autologous T-cell\u2013based therapies, including chimeric antigen receptor (CAR) T cells, have limited success in CLL, which has been attributed to an acquired CLL-mediated T-cell dysfunction and subset skewing toward effector cells at the expense of memory formation. T-cell responses rely on dynamic metabolic processes, particularly mitochondrial fitness. Although mitochondrial disruptions have been observed in solid tumor\u2013infiltrating lymphocytes, their impact on T-cell immunity in lymphoproliferative disorders is unknown. Recent findings indicate that mitochondrial mass in CAR T cells correlates with CLL clinical outcomes. This prompted our investigation into the mitochondrial fitness in CLL T cells. Integrated metabolic and functional analyses revealed impaired, depolarized mitochondria across all T-cell subsets in untreated patients with CLL, leading to further ex vivo and in vivo mouse studies on the underlying signaling alterations. Multiomics profiling of transcriptome and epigenome revealed significant alterations in mitochondrial signaling, diminished adenosine monophosphate-activated protein kinase and autophagy activity, and upregulated glycolysis coupled with hyperactivation of Akt. Inhibition of the phosphatidylinositol 3-kinase (PI3K)\/Akt pathway during CLL T-cell culture induced metabolic reprogramming, enhancing mitochondrial activity, expression of peroxisome proliferator-activated receptor-gamma coactivator 1-alpha, and memory differentiation. Underscoring clinical relevance, supplementation with the PI3K\u03b4 inhibitor idelalisib during CAR T-cell manufacturing improved persistence and long-term leukemia-free remissions in an immunocompetent murine model. Our study suggests that modulating the abnormal CLL T-cell metabolism can enhance the efficacy of autologous T-cell therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014822","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T16:01:16Z","timestamp":1739376076000},"page":"2511-2529","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-2601","authenticated-orcid":false,"given":"Wael","family":"Gamal","sequence":"first","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"},{"name":"2Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5597-346X","authenticated-orcid":false,"given":"Nienke B.","family":"Goedhart","sequence":"additional","affiliation":[{"name":"3Departments of Hematology and Experimental Immunology and Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-6133","authenticated-orcid":false,"given":"Helga","family":"Simon-Molas","sequence":"additional","affiliation":[{"name":"3Departments of Hematology and Experimental Immunology and Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Mediavilla-Varela","sequence":"additional","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angimar","family":"Uriepero-Palma","sequence":"additional","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-315X","authenticated-orcid":false,"given":"Fleur S.","family":"Peters","sequence":"additional","affiliation":[{"name":"3Departments of Hematology and Experimental Immunology and Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamira","family":"Maharaj","sequence":"additional","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Chavez","sequence":"additional","affiliation":[{"name":"4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-2645","authenticated-orcid":false,"given":"John","family":"Powers","sequence":"additional","affiliation":[{"name":"5Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-973X","authenticated-orcid":false,"given":"Alyssa","family":"Obermayer","sequence":"additional","affiliation":[{"name":"6Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-1924","authenticated-orcid":false,"given":"Timothy I.","family":"Shaw","sequence":"additional","affiliation":[{"name":"6Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Conejo-Garcia","sequence":"additional","affiliation":[{"name":"7Department of Integrative Immunobiology, Duke School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-6566","authenticated-orcid":false,"given":"Paulo C.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-2275","authenticated-orcid":false,"given":"Eva","family":"Sahakian","sequence":"additional","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"},{"name":"4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pinilla-Ibarz","sequence":"additional","affiliation":[{"name":"1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"},{"name":"4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-1891","authenticated-orcid":false,"given":"Arnon P.","family":"Kater","sequence":"additional","affiliation":[{"name":"3Departments of Hematology and Experimental Immunology and Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"1","key":"2025052708420852900_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ejh.14076","article-title":"CAR-T cell therapy in hematological malignancies: where are we now and where are we heading for?","volume":"112","author":"Khan","year":"2024","journal-title":"Eur J Haematol"},{"issue":"5","key":"2025052708420852900_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1182\/bloodadvances.2020003482","article-title":"Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia","volume":"6","author":"Grover","year":"2022","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"2025052708420852900_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2023-179529","article-title":"Lisocabtagene maraleucel (liso-cel) in R\/R CLL\/SLL: 24-month median follow-up of TRANSCEND CLL 004","volume":"142","author":"Siddiqi","year":"2023","journal-title":"Blood"},{"issue":"7","key":"2025052708420852900_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells","volume":"115","author":"G\u00f6rg\u00fcn","year":"2005","journal-title":"J Clin Investig"},{"issue":"9","key":"2025052708420852900_bib5","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2025052708420852900_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"2025052708420852900_bib7","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/bloodadvances.2022008985","article-title":"The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?","volume":"7","author":"Gamal","year":"2023","journal-title":"Blood Adv"},{"issue":"7","key":"2025052708420852900_bib8","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"J Clin Investig"},{"issue":"8","key":"2025052708420852900_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2025052708420852900_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De Novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"issue":"8","key":"2025052708420852900_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","article-title":"Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. [published correction appears in Nat Immunol. 2021;22(11):1465]","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat Immunol"},{"issue":"3","key":"2025052708420852900_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.immuni.2016.08.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"2025052708420852900_bib13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","article-title":"Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion","volume":"21","author":"Yu","year":"2020","journal-title":"Nat Immunol"},{"issue":"14","key":"2025052708420852900_bib14","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/bloodadvances.2022007034","article-title":"Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells","volume":"6","author":"van Bruggen","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"2025052708420852900_bib15","first-page":"44","article-title":"Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy","volume":"134","author":"van Bruggen","year":"2019","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"7","key":"2025052708420852900_bib16","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.4049\/jimmunol.180.7.4476","article-title":"Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways","volume":"180","author":"Jacobs","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"2025052708420852900_bib17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2007-08-108050","article-title":"CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85\/p110 heterodimer","volume":"111","author":"Gar\u00e7on","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2025052708420852900_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/0008-5472.CAN-23-0801","article-title":"Progressively enhancing stemness of adoptively transferred T cells with PI3K\u03b4 blockade improves metabolism and anti-tumor immunity","volume":"84","author":"Rangel Rivera","year":"2023","journal-title":"Cancer Res"},{"key":"2025052708420852900_bib19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fimmu.2017.01221","article-title":"PI3K\u03b4 inhibition enhances the antitumor fitness of adoptively transferred CD8+ T cells","volume":"8","author":"Bowers","year":"2017","journal-title":"Front Immunol"},{"issue":"15","key":"2025052708420852900_bib20","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1158\/0008-5472.CAN-16-1925","article-title":"Enhanced therapeutic efficacy and memory of tumor-specific CD8 T cells by ex vivo PI3K-\u03b4 inhibition","volume":"77","author":"Abu Eid","year":"2017","journal-title":"Cancer Res"},{"issue":"2","key":"2025052708420852900_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/0008-5472.CAN-14-2277","article-title":"Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics","volume":"75","author":"Crompton","year":"2015","journal-title":"Cancer Res"},{"issue":"4","key":"2025052708420852900_bib22","first-page":"523","article-title":"PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity","volume":"139","author":"Funk","year":"2022","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"5","key":"2025052708420852900_bib23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ijc.32201","article-title":"Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients","volume":"145","author":"Stock","year":"2019","journal-title":"Int J Cancer"},{"issue":"15","key":"2025052708420852900_bib24","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1073\/pnas.0901166106","article-title":"E\u03bc-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction","volume":"106","author":"Gorgun","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"35","key":"2025052708420852900_bib25","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1073\/pnas.1221740110","article-title":"CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability","volume":"110","author":"van der Windt","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2025052708420852900_bib26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/leu.2011.111","article-title":"Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL","volume":"25","author":"Hofbauer","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"2025052708420852900_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"7","key":"2025052708420852900_bib28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.celrep.2019.10.032","article-title":"NIX-mediated mitophagy promotes effector memory formation in antigen-specific CD8+ T cells","volume":"29","author":"Gupta","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"2025052708420852900_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10428194.2019.1660972","article-title":"CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion","volume":"61","author":"Lla\u00f3 Cid","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2025052708420852900_bib30","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004","article-title":"Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity","volume":"54","author":"Hanna","year":"2021","journal-title":"Immunity"},{"issue":"11","key":"2025052708420852900_bib31","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1038\/s41375-021-01198-1","article-title":"EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia","volume":"35","author":"Lla\u00f3-Cid","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"2025052708420852900_bib32","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41375-023-01817-z","article-title":"Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors","volume":"37","author":"Martens","year":"2023","journal-title":"Leukemia"},{"issue":"2","key":"2025052708420852900_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.15918","article-title":"Chronic lymphocytic leukaemia: the role of T cells in a B cell disease","volume":"186","author":"Man","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"2025052708420852900_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"Finck","year":"2006","journal-title":"J Clin Investig"},{"key":"2025052708420852900_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/9780470985571.ch2","article-title":"Transcriptional control of energy homeostasis through the PGC1 coactivators","volume":"286","author":"Spiegelman","year":"2007","journal-title":"Novartis Found Symp"},{"key":"2025052708420852900_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fgene.2019.00435","article-title":"Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways","volume":"10","author":"Gureev","year":"2019","journal-title":"Front Genet"},{"issue":"2","key":"2025052708420852900_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"2025052708420852900_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fcell.2019.00213","article-title":"Autophagy in T cell function and aging","volume":"7","author":"Macian","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2025052708420852900_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6316","key":"2025052708420852900_bib40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"issue":"6","key":"2025052708420852900_bib41","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ni.3438","article-title":"Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation","volume":"17","author":"Pollizzi","year":"2016","journal-title":"Nat Immunol"},{"issue":"9","key":"2025052708420852900_bib42","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.4049\/jimmunol.1103568","article-title":"Signal integration by Akt regulates CD8 T cell effector and memory differentiation","volume":"188","author":"Kim","year":"2012","journal-title":"J Immunol"},{"key":"2025052708420852900_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coi.2017.04.004","article-title":"The role of AMPK in T cell metabolism and function","volume":"46","author":"Ma","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2025052708420852900_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cmet.2015.11.002","article-title":"Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy","volume":"23","author":"Sukumar","year":"2016","journal-title":"Cell Metab"},{"issue":"8010","key":"2025052708420852900_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","article-title":"FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy","volume":"629","author":"Chan","year":"2024","journal-title":"Nature"},{"issue":"10","key":"2025052708420852900_bib46","doi-asserted-by":"crossref","first-page":"e2317735121","DOI":"10.1073\/pnas.2317735121","article-title":"Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with \u0394133p53\u03b1","volume":"121","author":"Roselle","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2025052708420852900_bib47","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.3390\/ijms25126324","article-title":"Optimization of in vitro Th17 polarization for adoptive cell therapy in chronic lymphocytic leukemia","volume":"25","author":"Gamal","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2025052708420852900_bib48","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"issue":"5","key":"2025052708420852900_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"2025052708420852900_bib50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","article-title":"Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection","volume":"51","author":"Hudson","year":"2019","journal-title":"Immunity"},{"issue":"39","key":"2025052708420852900_bib51","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by \u03b1PD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2025052708420852900_bib52","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"issue":"7620","key":"2025052708420852900_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"issue":"2","key":"2025052708420852900_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"issue":"6111","key":"2025052708420852900_bib55","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"issue":"11","key":"2025052708420852900_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2025052708420852900_bib57","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"2025052708420852900_bib58","doi-asserted-by":"crossref","first-page":"e148546","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J Clin Investig"},{"issue":"1","key":"2025052708420852900_bib59","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"2025052708420852900_bib60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41467-017-00520-9","article-title":"Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy","volume":"8","author":"Laker","year":"2017","journal-title":"Nat Commun"},{"issue":"15","key":"2025052708420852900_bib61","doi-asserted-by":"crossref","first-page":"eabg4544","DOI":"10.1126\/sciadv.abg4544","article-title":"AMPK\/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy","volume":"7","author":"Hung","year":"2021","journal-title":"Sci Adv"},{"issue":"8","key":"2025052708420852900_bib62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41422-020-0379-5","article-title":"Metabolic signaling in T cells","volume":"30","author":"Shyer","year":"2020","journal-title":"Cell Res"},{"issue":"3","key":"2025052708420852900_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molcel.2013.03.022","article-title":"Inhibition of AMPK catabolic action by GSK3","volume":"50","author":"Suzuki","year":"2013","journal-title":"Mol Cell"},{"issue":"11","key":"2025052708420852900_bib64","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2025052708420852900_bib65","doi-asserted-by":"crossref","first-page":"e0190854","DOI":"10.1371\/journal.pone.0190854","article-title":"Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy","volume":"13","author":"Sathe","year":"2018","journal-title":"PLoS One"},{"issue":"13","key":"2025052708420852900_bib66","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/bloodadvances.2020001800","article-title":"The dual PI3K\u03b4\/CK1\u03b5 inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells","volume":"4","author":"Maharaj","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"2025052708420852900_bib67","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.3109\/10428194.2015.1022770","article-title":"Management of adverse events associated with idelalisib treatment: expert panel opinion","volume":"56","author":"Coutr\u00e9","year":"2015","journal-title":"Leuk Lymphoma"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/10\/2511\/2375092\/blooda_adv-2024-014822-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/10\/2511\/2375092\/blooda_adv-2024-014822-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:42:23Z","timestamp":1748335343000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/10\/2511\/535574\/Mitigating-T-cell-mitochondrial-dysfunction-in-CLL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014822","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,27]]},"published":{"date-parts":[[2025,5,19]]}}}